Think

Search This Blog

Why Silicon Valley Keeps Getting Biotechnology Wrong

April 18, 2017

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Why Silicon Valley Keeps Getting Biotechnology Wrong via Digg

Digg IFTTT

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo. Pam Belluck | NYTimes Health | Disclosure

Many U.S. virus cases go uncounted. Are there better ways to track the pandemic?

BY EMILY ANTHES | NYTimes Health | Disclosure

A new drug slashes deaths among patients with severe Covid, the drug’s developer claims.

BY RONI CARYN RABIN | NYTimes Health | Disclosure

Hospitals Must Get Written Patient Consent for Pelvic Exams, H.H.S. Says

In a letter to teaching hospitals, the federal health agency said that institutions could lose Medicare funding if they didn’t comply. Emma Goldberg | NYTimes Health | Disclosure

Close to Half of American Adults Infected With Genital HPV, Study Finds

According to a survey published by the National Center for Health Statistics, more than 42 percent of Americans between the ages of 18 and 59 are infected with genital human papillomavirus (HPV). By NICHOLAS BAKALAR via NYT Health

Powered by Blogger

Why Silicon Valley Keeps Getting Biotechnology Wrong

Comments

Post a Comment